Katherine Ayling-Rouse

Katherine Ayling-Rouse is an experienced scientific director currently serving at Muse Medical Communications Ltd since May 2021 and at Envision Pharma Group since September 2017, where also holds the role of Principal Writer. Prior experience includes positions as a Scientific Specialist at Parexel from October 2004 to October 2017, a Scientific Writer at Wells Healthcare from August 2001 to September 2003, a Research Associate at Novartis from August 1998 to August 2001, and a Medical Laboratory Scientist at Leicester Royal Infirmary from September 1993 to July 1998. Katherine holds a Master's degree in Immunology from Sheffield Hallam University and a BSc (Hons) in Biological and Biomedical Sciences from the University of the West of England.